138 related articles for article (PubMed ID: 26254096)
1. Prognostic significance of serum ERBB3 and ERBB4 mRNA in lung adenocarcinoma patients.
Masroor M; Javid J; Mir R; Y P; A I; Z M; Mohan A; Ray PC; Saxena A
Tumour Biol; 2016 Jan; 37(1):857-63. PubMed ID: 26254096
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and prognostic values of ErbB receptor family amplification in primary osteosarcoma.
Huang Z; Wang SL; Chen H; Shen RK; Li XD; Huang QS; Wu CY; Weng DF; Lin JH
Scand J Clin Lab Invest; 2019 Dec; 79(8):601-612. PubMed ID: 31663373
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of ERBB family mRNA expression in breast carcinomas.
Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R
Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037
[TBL] [Abstract][Full Text] [Related]
4. Association of ErbB1-4 expression in invasive breast cancer with clinicopathological characteristics and prognosis.
Fujiwara S; Ibusuki M; Yamamoto S; Yamamoto Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):472-81. PubMed ID: 23100016
[TBL] [Abstract][Full Text] [Related]
5. Detection of HER2 polymorphism and expression using circulating DNA and RNA as a tool in lung adenocarcinoma patients: a case control study.
Mirza M; Javid J; Yadav P; Mohan A; Ray PC; Saxena A
Ann Transl Med; 2016 Jun; 4(11):209. PubMed ID: 27386483
[TBL] [Abstract][Full Text] [Related]
6. [Relationship of expression of C-erbB2, C-erbB3, and C-erbB4 with ovarian carcinoma].
Li L; Zhong YP; Zhang W; Zhang JQ; Yao ZQ
Ai Zheng; 2004 May; 23(5):568-72. PubMed ID: 15142456
[TBL] [Abstract][Full Text] [Related]
7. ErbB2, ErbB3 and ErbB4 expression in urothelial tumors of the upper urinary tract and their prognostic significance.
Galanakis I; Spyropoulos E; Gkialas I; Nomikos A; Souka E; Mitropoulos D
J BUON; 2013; 18(3):653-9. PubMed ID: 24065479
[TBL] [Abstract][Full Text] [Related]
8. Association of EGFR 1 Gene Alteration and their Association with Lung Adenocarcinoma Patients.
Ali Beg MM; Fahdil SR; Yadav P; Shukla KK; Mohan A; Saxena A
Asian Pac J Cancer Prev; 2019 Mar; 20(3):825-830. PubMed ID: 30912007
[TBL] [Abstract][Full Text] [Related]
9. ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomas.
Silva SD; Cunha IW; Younes RN; Soares FA; Kowalski LP; Graner E
Oral Dis; 2010 Nov; 16(8):774-80. PubMed ID: 20604875
[TBL] [Abstract][Full Text] [Related]
10. [Expression and significance of ErbB3 and ErbB4 in patients with laryngeal squamous cell carcinomas].
Ming W; Hua Q; Tao Z; Zhang D
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Aug; 21(15):706-8. PubMed ID: 17969526
[TBL] [Abstract][Full Text] [Related]
11. Thyroid transcription factor-1 amplification and expressions in lung adenocarcinoma tissues and pleural effusions predict patient survival and prognosis.
Li X; Wan L; Shen H; Geng J; Nie J; Wang G; Jia N; Dai M; Bai X
J Thorac Oncol; 2012 Jan; 7(1):76-84. PubMed ID: 22011671
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of ERBB4 expression in patients with triple negative breast cancer.
Kim JY; Jung HH; Do IG; Bae S; Lee SK; Kim SW; Lee JE; Nam SJ; Ahn JS; Park YH; Im YH
BMC Cancer; 2016 Feb; 16():138. PubMed ID: 26907936
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions.
Kasapoglu US; Arınç S; Gungor S; Irmak I; Guney P; Aksoy F; Bandak D; Hazar A
Clin Respir J; 2016 Nov; 10(6):791-799. PubMed ID: 25764010
[TBL] [Abstract][Full Text] [Related]
14. ErbB3 mRNA expression correlated with specific clinicopathologic features of Japanese lung cancers.
Kawano O; Sasaki H; Endo K; Suzuki E; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
J Surg Res; 2008 May; 146(1):43-8. PubMed ID: 17631905
[TBL] [Abstract][Full Text] [Related]
15. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
[TBL] [Abstract][Full Text] [Related]
16. AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma.
Albertus DL; Seder CW; Chen G; Wang X; Hartojo W; Lin L; Silvers A; Thomas DG; Giordano TJ; Chang AC; Orringer MB; Bigbee WL; Chinnaiyan AM; Beer DG
J Thorac Oncol; 2008 Nov; 3(11):1236-44. PubMed ID: 18978557
[TBL] [Abstract][Full Text] [Related]
17. c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer.
Knowlden JM; Gee JM; Seery LT; Farrow L; Gullick WJ; Ellis IO; Blamey RW; Robertson JF; Nicholson RI
Oncogene; 1998 Oct; 17(15):1949-57. PubMed ID: 9788438
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma.
Sato Y; Fujimoto D; Uehara K; Shimizu R; Ito J; Kogo M; Teraoka S; Kato R; Nagata K; Nakagawa A; Otsuka K; Hamakawa H; Takahashi Y; Imai Y; Tomii K
BMC Cancer; 2016 Nov; 16(1):890. PubMed ID: 27842505
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Maspin mRNA Expression is Associated with Clinical Outcome in Patients with Pulmonary Adenocarcinoma.
Lu M; Li J; Huang Z; Du Y; Jin S; Wang J
Med Sci Monit; 2016 Jan; 22():134-9. PubMed ID: 26757744
[TBL] [Abstract][Full Text] [Related]
20. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]